Jaguar Health (JAGX) Fundamental Analysis: Revenue, Earnings & Valuation

0.84 / 10

Underperform

Fundamental score is 0.84/10, classified as Underperform. Key ratios such as ROE (-381.8), ROA (-53.4), and diluted ROE (-1007) rank in the lowest quartile, delivering negative monthly returns. Only Net‑profit/Total‑profit (100%) shows a modest positive factor. Overall fundamentals are weak.

Analysis Checks(0/6)

ROA (%)

Value-53.43

Score0/3

Weight18.45%

1M Return-6.12%

Annualized return on equity (%)

Value-763.68

Score0/3

Weight17.63%

1M Return-5.73%

Annualized net profit margin on total assets (%)

Value-106.85

Score0/3

Weight18.45%

1M Return-6.12%

ROE (diluted) (%)

Value-1007.11

Score0/3

Weight18.52%

1M Return-5.82%

ROE (%)

Value-381.84

Score0/3

Weight17.63%

1M Return-5.73%

Net profit / Total profit (%)

Value100.00

Score1/3

Weight9.33%

1M Return-2.37%

Is JAGX fundamentally strong?

JAGX scores 0.84/10 on fundamentals and holds a Premium valuation at present. Backed by its -455.44% ROE, -348.22% net margin, -0.11 P/E ratio, 1.02 P/B ratio, and -100.53% earnings growth, these metrics solidify its Underperform investment rating.